iSpecimen Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities
iSpecimen Inc. (ISPC) reported Interest Paid, Excluding Capitalized Interest, Operating Activities of $1.95 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaidNet · last filed 2026-08-14
- iSpecimen Inc. interest paid, excluding capitalized interest, operating activities for the quarter ending 2025-12-31 was $0.00.
- iSpecimen Inc. interest paid, excluding capitalized interest, operating activities for the quarter ending 2025-09-30 was $2.00, a 99.96% decline year-over-year.
- iSpecimen Inc. interest paid, excluding capitalized interest, operating activities for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- iSpecimen Inc. interest paid, excluding capitalized interest, operating activities for the quarter ending 2025-03-31 was $1.95K, a 56.42% decline year-over-year.
- iSpecimen Inc. interest paid, excluding capitalized interest, operating activities for fiscal 2025 was $1.95K, a 86.43% decline from fiscal 2024.
- iSpecimen Inc. interest paid, excluding capitalized interest, operating activities for fiscal 2024 was $14.36K, a 10.27% decline from fiscal 2023.
- iSpecimen Inc. interest paid, excluding capitalized interest, operating activities for fiscal 2023 was $16.00K, a 90.10% decline from fiscal 2022.
- iSpecimen Inc. interest paid, excluding capitalized interest, operating activities for fiscal 2022 was $161.58K, a 94.28% decline from fiscal 2021.
| Period end | Interest Paid, Excluding Capitalized Interest, Operating Activities 3 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 6 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 9 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 12 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $2.00 derived: sum of 2 quarters · filed 2026-04-01 | $2.00 derived: sum of 3 quarters · filed 2026-08-14 | $1.95K 10-K · filed 2026-04-01 | |
| 2025-09-30 | $2.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $2.00 derived: sum of 2 quarters · filed 2026-08-14 | $1.95K 10-Q · filed 2025-11-17 | $1.95K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.95K 10-Q · filed 2026-08-14 | $1.95K derived: sum of 3 quarters · filed 2026-08-14 | $7.37K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $1.95K 10-Q · filed 2026-05-18 | $1.95K derived: sum of 2 quarters · filed 2026-05-18 | $7.37K derived: sum of 3 quarters · filed 2026-05-18 | $11.84K derived: sum of 4 quarters · filed 2026-05-18 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $5.42K derived: sum of 2 quarters · filed 2026-04-01 | $9.89K derived: sum of 3 quarters · filed 2026-04-01 | $14.36K 10-K · filed 2026-04-01 | $33.75K 10-K · filed 2025-04-14 |
| 2024-09-30 | $5.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $9.89K derived: sum of 2 quarters · filed 2025-11-17 | $14.36K 10-Q · filed 2025-11-17 | $18.82K derived: sum of 4 quarters · filed 2025-11-17 | |
| 2024-06-30 | $4.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $8.94K 10-Q · filed 2025-08-14 | $13.40K derived: sum of 3 quarters · filed 2025-08-14 | $17.87K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $4.46K 10-Q · filed 2025-05-19 | $8.93K derived: sum of 2 quarters · filed 2025-05-19 | $13.40K derived: sum of 3 quarters · filed 2025-05-19 | $16.93K derived: sum of 4 quarters · filed 2025-05-19 | |
| 2023-12-31 | $4.47K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-14 | $8.93K derived: sum of 2 quarters · filed 2025-04-14 | $12.47K derived: sum of 3 quarters · filed 2025-04-14 | $16.00K 10-K · filed 2025-04-14 | |
| 2023-09-30 | $4.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $8.00K derived: sum of 2 quarters · filed 2024-11-07 | $11.54K 10-Q · filed 2024-11-07 | $51.19K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $3.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $7.07K 10-Q · filed 2024-08-06 | $46.72K derived: sum of 3 quarters · filed 2024-08-06 | $94.44K derived: sum of 4 quarters · filed 2024-08-06 | |
| 2023-03-31 | $3.54K 10-Q · filed 2024-05-07 | $43.19K derived: sum of 2 quarters · filed 2024-05-07 | $90.91K derived: sum of 3 quarters · filed 2024-05-07 | $130.11K derived: sum of 4 quarters · filed 2024-05-07 | |
| 2022-12-31 | $39.65K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $87.37K derived: sum of 2 quarters · filed 2024-03-13 | $126.58K derived: sum of 3 quarters · filed 2024-03-13 | $161.58K 10-K · filed 2024-03-13 | |
| 2022-09-30 | $47.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $86.93K derived: sum of 2 quarters · filed 2023-11-02 | $121.93K 10-Q · filed 2023-11-02 | $121.93K derived: sum of 4 quarters · filed 2023-11-02 | |
| 2022-06-30 | $39.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $74.20K 10-Q · filed 2023-08-02 | $74.20K derived: sum of 3 quarters · filed 2023-08-02 | $74.20K derived: sum of 4 quarters · filed 2023-08-02 | |
| 2022-03-31 | $35.00K 10-Q · filed 2023-05-04 | $35.00K derived: sum of 2 quarters · filed 2023-05-04 | $35.00K derived: sum of 3 quarters · filed 2023-05-04 | ||
| 2021-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $2.82M 10-K/A · filed 2023-03-30 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.82M 10-Q · filed 2022-11-08 | |||
| 2021-06-30 | $2.82M 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |